The Safety of Discontinuation of Maintenance Therapy for Cytomegalovirus (CMV) Retinitis and Incidence of Immune Recovery Uveitis Following Potent Antiretroviral Therapy

REFERENCES

• PaleIla FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853.
   PubMed Web of Science ®Google Scholar
• Holtzer CD, Jacobson MA, Hadley WK, et al. Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997. AIDS. 1998;12:1931.
   PubMed Web of Science ®Google Scholar
• Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham ET. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000; 30:231.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Chie Y, Genka I, et al. Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS. AIDS Res Hum Retrov. 20011749–1756
   PubMed Web of Science ®Google Scholar
• Torriani F, Freeman W, MacDonald J, et al. CMV retinitis recurs after stopping treatment in virological and immuno-logical failures of potent antiretroviral therapy. AIDS. 2000;14:173–180
   PubMed Web of Science ®Google Scholar
• Tural C, Romeu J, Sirera G, et al. Long lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis. 1998;177:1080–1083.
   PubMed Web of Science ®Google Scholar
• Reed J, Schwab I, Gordon J, et al. Regression of cytome-galovirus retinitis associated with protease inhibitor treat-ment in patients with AIDS. Am J OphthalmoL 1997; 124:199–205.
   PubMed Web of Science ®Google Scholar
• MacDonald J, Torriani F, Morse L, et al. Lack of reactiva-tion of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained el-evation of CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis. 1998;117:1182–1187.
   Web of Science ®Google Scholar
• Whitcup S, Fortin E, Nussenblatt R, et al. Therapeutic effect of combination antiretroviral therapy on cytomega-lovirus retinitis. JAMA. 1997;277:1519–1520.
   PubMed Web of Science ®Google Scholar
• Vrabec T, Baldassano V, Whitcup S, et al. Discontinuation of maintenance therapy in patients with quiescent cytome-galovirus retinitis and elevated CD4+ counts. Ophthalmol-ogy. 1998;105:1259–1264.
   PubMed Web of Science ®Google Scholar
• Whitcup S, Cunningham E, Polis M, et al. Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy. Br J OphthalmoL 1998;82:845–846.
   PubMed Web of Science ®Google Scholar
• Jabs D, Bolston S, Dunn J, et al. Discontinuing anticytomegalovirus therapy in patients with immune re-constitution after combination of antiretroviral therapy. Am J OphthalmoL 1998;126:817–822.
   PubMed Web of Science ®Google Scholar
• Whitcup S, Fortin E, Lindblad A, et al. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and CMV retinitis. JAMA. 1999;282:1633–1637.
   PubMed Web of Science ®Google Scholar
• MacDonald J, Karavellas M, Torriani F, et al. Highly active antiretroviral therapy related immune recovery in AIDS pa-tients with cytomegalovirus retinitis. Ophthalmology. 2000;107:877–881.
   PubMed Web of Science ®Google Scholar
• DeSimone J, Pomerantz R, Babinchak T. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med. 2000;133:447–454.
   PubMed Web of Science ®Google Scholar
• Kupperman B, Holland G. Immune recovery uveitis. Am J OphthalmoL 2000;103:103–106.
   Web of Science ®Google Scholar
• Nguyen Q, Kempen J, Bolton S, et al. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J OphthalmoL 2000;129:634–639.
   PubMed Web of Science ®Google Scholar
• Zegans M, Walton R, Holland G, et al. Transient vitretous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomega-lovirus retinitis. Am J OphthalmoL 1998;125:292–300.
   PubMed Web of Science ®Google Scholar
• Karavellas M, Plummer D, MacDonald J, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis pa-tients following institution of successful highly active antiretroviral therapy. J Infect Dis. 1999;179:697–700.
   PubMed Web of Science ®Google Scholar
• Karavellas M, Azen S, MacDonald J, et al. Immune recov-ery vitritis in AIDS: clinical predictors, sequellae and treat-ment outcomes. Retina. 200121: 1–9.
   Google Scholar
• Mutimer H, Akatsuka Y, Manley T, et al. Association be-tween immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J In-fect Dis. 2002;186:701–705.
   PubMed Web of Science ®Google Scholar
• Ambati J, Wynne K, Angerame M, et al. Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis. Br J OphthalmoL 1999;83:1153–1158.
   PubMed Web of Science ®Google Scholar
• Chavez-de la Paz E, Arevalo JF, Kirsch LS, et al. Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. Ophthalmology. 1997;104(3): 539–544.
   PubMed Web of Science ®Google Scholar
• Song M, Azen S, Buley A, et al. Effect of anti-cytomegalovi-rus therapy on the incidence of immune recovery uvetitis in AIDS patients with healed cytomegalovirus retinitis. Am J OphthalmoL 2003;136:696–702.
   PubMed Web of Science ®Google Scholar
• Kosobucki BR, Goldberg DE, Bessho K, et al. Valganciclovir therapy for immune recovery uveitis compli-cated by macular edema. Am JOphthalmoL 2004;137:633.
   Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Thorne JE, et al. Course of cy-tomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmol-ogy. 2004;111(12):2224–2231.
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Masur H, Holmes KK, et al. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-8):1–52.
   Google Scholar
• Song MK, Azen SP, Buley A, et al. Effect of anti-cytomega-lovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J OphthalmoL 2003;136(4):696–702.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Kempen JH, Bolton SG, et al. Immune recov-ery uveitis in patients with AIDS and cytomegalovirus re-tinitis after highly active antiretroviral therapy. Am J OphthalmoL 2000;129(5):634–639.
   PubMed Web of Science ®Google Scholar
• Blank BS, Meenhorst PL, Mulder JW, et al. Value of differ-ent assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients. J Clin MicrobioL 2000;38(2):563–569.
   PubMed Web of Science ®Google Scholar